April 25, 2017 by Chain Drug Review
Adrenaclick, Amedra Pharmaceuticals, epinephrine auto-injectors, EpiPen, Jennifer Speares Lehman, Kmart, Kmart Pharmacy, mylan
Leading Headlines, Pharmacy, Retail News

HOFFMAN ESTATES, Ill. — Kmart Pharmacy is tackling the cost issue with epinephrine auto-injectors for anaphylaxis by knocking down the price of a generic version. Kmart said Tuesday that in response to the sharp hikes in price of epinephrine auto-injector pens, it has lowered the cost of the generic version of Adrenaclick to as low
February 6, 2017 by Scot Meyer and Chain Drug Review
Adrenaclick, Amedra Pharmaceuticals, CVS Health, CVS Pharmacy, Douglas Boothe, epinephrine auto-injector, EpiPen, Helena Foulkes, Impax Laboratories, mylan
2017, Issue 02-06-2017, Issues, News
WOONSOCKET, R.I. — CVS Health is providing a low-cost alternative Mylan’s EpiPen epinephrine auto-injector for anaphylaxis. CVS has made Impax Laboratories’ epinephrine auto-injector available at all CVS Pharmacy drug stores at a cash price of $109.99 for a two-pack. That compares with a cash price of $649.99 for the branded EpiPen and $339.99 for the
January 12, 2017 by Chain Drug Review
Adrenaclick, Adrenaclick authorized generic, Amedra Pharmaceuticals, Auvi-Q, CVS Health, CVS Pharmacy, Douglas Boothe, epinephrine auto-injector, EpiPen, EpiPen authorized generic, Helena Foulkes, Impax Laboratories, Kaleo, mylan
Leading Headlines, Pharmacy, Retail News

WOONSOCKET, R.I. — In the wake of the public outcry over pricing for Mylan’s EpiPen epinephrine auto-injector for anaphylaxis, CVS Health announced that it’s providing a low-cost alternative. CVS said Thursday that Impax Laboratories’ authorized generic for the Adrenaclick epinephrine auto-injector is now available at all CVS Pharmacy drug stores at a cash price of $109.99
August 31, 2016 by Chain Drug Review
Adrenaclick, Amedra Pharmaceuticals, anaphylaxis, EpiPen, generic epinephrine auto-injector, Impax Laboratories, mylan
Pharmacy, Supplier News

HAYWARD, Calif. — Impax Laboratories Inc. is spotlighting its generic epinephrine auto-injector amid a public outcry over the cost of emergency medication for anaphylaxis, a potentially life-threatening allergic reaction. In what Impax called an update, the company said it’s providing additional information to patients, doctors and customers about its epinephrine injection auto-injector in 0.15-mg and